Source: Eur Respir J 2008; 32: 571-578
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Williams A. S., Nath P., Leung S-Y., Khorasani N., McKenzie A. N. J., Adcock I. M., Chung K. F.. Modulation of ozone-induced airway hyperresponsiveness and inflammation by interleukin-13. Eur Respir J 2008; 32: 571-578

Member's Comments

No comment yet.

Related content which might interest you: Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation and remodelling Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside Year: 2007 Corticosteroid-resistant neutrophilic airway inflammation and hyperresponsiveness caused by IL-13 Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018 Interleukin (IL-13) modulates allergen-induced airway hyperresponsiveness by a pathway independent of IL-5 or eotaxin in mice Source: Eur Respir J 2003; 22: Suppl. 45, 194s Year: 2003 Role of Rho kinase isoforms in murine allergic airway responses Source: Eur Respir J 2011; 38: 841-850 Year: 2011 The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007 The role of CCR5 in allergen-induced airway hyperresponsiveness and airway inflammation Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Role of macrophage migration inhibitory factor in ovalbumin-induced airway inflammation in rats Source: Eur Respir J 2006; 27: 726-734 Year: 2006 Interleukin-17 in induced sputum correlates with airway hyperresponsiveness to methacholine Source: Eur Respir J 2001; 18: Suppl. 33, 193s Year: 2001 IL-13 induces glucocorticoid-insensitive hyperreactivity of human small airways Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma Source: Eur Respir J 2001; 18: 444-450 Year: 2001 Role of IL-33 signaling in pollutant-induced allergic airway inflammation Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 Anti-cytokine approaches should target bronchial hyperresponsiveness rather than inflammation – Pro Source: Annual Congress 2006 - Pro/Con: asthma is (not) an inflammatory disease Year: 2006 Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice Source: Eur Respir J 2009; 34: 200-208 Year: 2009 The effect of Der f-induced airway inflammation on airway inflammation in a murine model of allergic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 348s Year: 2004 Effect of neutrophil elastase inhibitor on airway inflammation and airway hyperresponsiveness in a murine model of asthma Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide- but not allergen-induced airway neutrophilia Source: Eur Respir J 2002; 20: Suppl. 38, 618s Year: 2002 IL-10 and IL-1ra mediates OVA-induced Th2 airway allergic response at short and long-term Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 CCL6 produced by eosinophils drives allergic airway inflammation in mice Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 Allergen-induced airway responses Source: Eur Respir J 2015; 46: 819-831 Year: 2015